These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6108378)

  • 41. [Clinical evaluation of the anti-arrhythmic properties and cardiohemodynamic effects of the basic anti-arrhythmia agents].
    Stoliarchuk AA; Storozhuk BG; Briskin VR
    Farmakol Toksikol; 1985; 48(1):5-10. PubMed ID: 3979536
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute myocardial infarct and pindolol. Effect of a beta sympatholytic with intrinsic sympathomimetic activity on hemodynamics and contractility].
    Hübner H; Stephan K; Meesmann W; Abendroth RR
    Arzneimittelforschung; 1976; 26(8):1561-5. PubMed ID: 1036952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

  • 44. [Pharmacological treatment of arrhythmia following acute myocardial infarct].
    Aleksandrow W
    Kardiol Pol; 1975; 18(1):5-9. PubMed ID: 235033
    [No Abstract]   [Full Text] [Related]  

  • 45. [Efficacy of treatment with inderal and visken of patients with circulatory insufficiency].
    Shevchenko IA; Marchenko AM; Simonenko VB
    Voen Med Zh; 1983 Feb; (2):51-3. PubMed ID: 6133395
    [No Abstract]   [Full Text] [Related]  

  • 46. [Clinical experience with the use of nitroglycerin in the acute period of myocardial infarct].
    Orlov LL; Shilov AM; Roĭtberg GE
    Kardiologiia; 1984 Sep; 24(9):27-31. PubMed ID: 6441065
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of beta-adrenergic blockaders in the treatment of arterial hypertension].
    Erina EV; Basishvili NZ
    Kardiologiia; 1978 Mar; 18(3):28-35. PubMed ID: 25351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of beta adrenergic blocking on the arrhythmias following coronary ligation in rat.
    Kenedi I; Losonci A
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):247-57. PubMed ID: 4143381
    [No Abstract]   [Full Text] [Related]  

  • 49. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Changes in the echocardiographic indices in patients with acute myocardial infarct treated with viscen].
    el-Assali D; Cherevatov BG; Boiarshin SV; Tarnakin AG
    Vrach Delo; 1983 Jan; (1):18-20. PubMed ID: 6135279
    [No Abstract]   [Full Text] [Related]  

  • 51. [The characteristics of using visken in middle-aged and elderly patients with arterial hypertension].
    Tokar AV; Iena LM; Kozymenko TM; Shyshkina OS
    Lik Sprava; 1993; (10-12):34-8. PubMed ID: 8030304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [LB-46 in the treatment of angina pectoris, arrhythmia and functional cardiac disorders].
    Latorre A; Lenti M; Calabrese P
    Minerva Cardioangiol; 1976 Sep; 24(9):619-24. PubMed ID: 1012502
    [No Abstract]   [Full Text] [Related]  

  • 53. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 54. Review of beta blocker myocardial infarction trials.
    Goldstein S
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III54-7. PubMed ID: 2575021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined use of glucagon and beta-adrenoceptor antagonists in ventricular arrhythmias accompanying myocardial infarction.
    Madan BR; Jain BK
    Indian J Med Res; 1973 Oct; 61(10):1535-43. PubMed ID: 4781011
    [No Abstract]   [Full Text] [Related]  

  • 56. [Use of glucagon in cardiac insufficiency].
    Golikov AP; Berestov AA
    Kardiologiia; 1975 Oct; 15(10):62-5. PubMed ID: 1234916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
    Singh BN
    N Z Med J; 1973 Dec; 78(505):529-35. PubMed ID: 4150209
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effect of quaternary salts of exaprolol on disorders of cardiac rhythm in experimental myocardial infarct].
    Kittová M; Drímal J
    Bratisl Lek Listy; 1984 Aug; 82(2):963-72. PubMed ID: 6149002
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of hypertension with a combination of pyridopyridazine derivative with a beta-receptor blocker. Studies on the hemodynamic course (author's transl)].
    Lehmann HU; Witt E; Hochrein H
    MMW Munch Med Wochenschr; 1978 Jun; 120(23):803-6. PubMed ID: 26870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of prophylactic antiarrhythmic treatment on the incidence of ventricular arrhythmias in the postinfarction period (author's transl)].
    Wolf R; Sinn R; Guillen R
    Z Kardiol; 1982 Jan; 71(1):26-30. PubMed ID: 6175118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.